Dialog
User can designate cutting region by dragging or precise genomic coordinates
cutStart
Set
cutEnd
Set
Close
Apply

STATISTICS

Sample & DescriptionGEO IdsRaw read countsProperly aligned readsValid interaction readsReference genome
MCF10 cell line (ER-/PR- fibrocystic disease)GSM341709818088606912567861149228102hg38
BT474 cell line (ER+/PR+ breast cancer cell line)GSM341710214673781210461210950144320hg38
SKBR3 cell line (ER-/PR- adenocarcinoma)GSM341710917336112212128660248871904hg38
Embryonic stem cell, Cardiomyocyte differentiation : hESCs (day 0)GSM3262956, GSM3262957306544305123204911921285311235hg38
Embryonic stem cell, Cardiomyocyte differentiation : cardiac progenitors (day 7)GSM3262962, GSM3262963263314964519895878401184379812hg38
Embryonic stem cell, Cardiomyocyte differentiation : primitive cardiomyocytes (day 15)GSM3262964, GSM3262965264599722520106698871113062173hg38
Embryonic stem cell, Cardiomyocyte differentiation : ventricular cardiomyocytes (day 80)GSM3262966, GSM3262967279136054221076786161186372639hg38
Embryonic stem cellGSM3263085, GSM3263086552532207423393820306106105hg38
Embryonic stem cell, HERV-H1 Knock-Out, HERV-H elements located TAD boundaries were deleted using CRISPR?Cas9GSM3263087, GSM3263088606526176464991357335198946hg38
Embryonic stem cell, HERV-H2 Knock-Out, HERV-H elements located TAD boundaries were deleted using CRISPR?Cas9GSM3263089, GSM3263090635909624488199946350004302hg38
Embryonic stem cell, HERV-H1 CRISPRiGSM3734950, GSM3734951264104080177046213145540552hg38
Embryonic stem cell, HERV-H2 CRISPRiGSM3734952, GSM3734953278214140188031209156571323hg38
Embryonic stem cell, HERV-H2-insertion clone1GSM3734958, GSM3734959551761465413295286305877518hg38
Embryonic stem cell, HERV-H2-insertion clone2GSM3734960, GSM3734961555274478418410249302808720hg38
teloHAEC (endothelial cell line)GSM3593256, GSM359325715884753171083869648597523217hg38
teloHAEC (endothelial cell line), TNF_ treated, 4hourGSM3593258, GSM359325916720740291139419192616723577hg38
primary white blood cellGSM3560407, GSM35604081001632098579240864279320427hg38
primary neutrophil cellGSM356040919645646411126798770501305176hg38
HEK293T (embryonic kidney cell line), transfected with dCas9-VPR targeting the promoter CTCF binding site of Pcdha12GSM3514558, GSM3514559, GSM351456023603287616091338729305790hg38
HEK293T (embryonic kidney cell line), transfected with dCas9-VPR targeting the exon CTCF binding site of Pcdha12GSM3514561, GSM3514562, GSM351456323038363814431393226813179hg38
HUVEC (umblical vein endothelial cells)GSM3438650, GSM3438651360069151273451397146408594hg38
HUVEC (umblical vein endothelial cells), treated 10 ng/ml TNF-_, 1hourGSM3438652, GSM3438653361675769277047686151574445hg38
Peripheral blood neutrophilsGSM3612251, GSM3612252, GSM36122531292462868375401632206699hg38
Peripheral blood neutrophils, treat 25nM PMA, 3hourGSM3612254, GSM3612255, GSM3612256391792697288684798211578071hg38
Peripheral blood neutrophils, co-cultured with E.coli K1, 3hourGSM3612257, GSM3612258931754706204354819997046hg38
ASCs (Adipose-Derived Stem Cells), 0 day of differentiation inductionGSM2973922, GSM297392346111431833881853790312681hg38
ASCs (Adipose-Derived Stem Cells), 1 day of differentiation inductionGSM2973924, GSM2973925557681835450140489120917711hg38
ASCs (Adipose-Derived Stem Cells), 3 day of differentiation inductionGSM3394773, GSM339472779864248924398471943488065hg38
ASCs (Adipose-Derived Stem Cells), 2 days before induction of differentiationGSM2973928, GSM2973929447238034344442038154678155hg38
ASCs (Adipose-Derived Stem Cells), 1 day after neuronal inductionGSM2973930, GSM2973931102406341576556665569276217hg38
ASCs (Adipose-Derived Stem Cells), 3 day after neuronal inductionGSM2973932, GSM2973933841217186538711679136250162hg38
Na•ve human embryonic stem cells, growth condition: GSKi + MEKi (2i), Lif, IGF1, FGFGSM2410309, GSM241031015690279771098155835610379770hg38
ADAC418 (primary islet)GSM333389831132103732312969803818402658hg38
EndoC-_H1 cells (pancreatic beta cell line)GSM333391629794486952166636763710726913hg38
GM23248 (primary skin fibroblasts)GSM3506961, GSM3506962, GSM3506963, GSM3506964, GSM3506965,
GSM3506966, GSM3506967, GSM3506968, GSM3506969, GSM3506970		23391745541622776059678483853hg38
HTBE (human tracheobronchial epithelial cells), infect active H5N1 influenza, infection time 12hourGSM3112369, GSM3112370379673223274630670150818035hg38
HTBE (human tracheobronchial epithelial cells), infect UV-inactived H5N1 influenza, infection time 12hourGSM3112371, GSM3112372362519567263386426136370297hg38
HTBE (human tracheobronchial epithelial cells), infect mock, infection time 12hourGSM3112373, GSM3112374366038580263501503137266211hg38
HTBE (human tracheobronchial epithelial cells), infect active H5N1 influenza, infection time 18hourGSM3112375, GSM3112376375805175274612117156023009hg38
HTBE (human tracheobronchial epithelial cells), infect UV-inactived H5N1 influenza, infection time 18hourGSM3112377, GSM3112378389553610286177447154089580hg38
HTBE (human tracheobronchial epithelial cells), infect mock, infection time 18hourGSM3112379, GSM3112380377989499272732142143348203hg38
HTBE (human tracheobronchial epithelial cells), infect active H5N1 influenza, infection time 6hourGSM3112381, GSM3112382259797113190293754103982906hg38
HTBE (human tracheobronchial epithelial cells), infect UV-inactived H5N1 influenza, infection time 6hourGSM3112383, GSM3112384373113215273668222147941389hg38
HTBE (human tracheobronchial epithelial cells), infect mock, infection time 6hourGSM3112385, GSM3112386393316499284747076151571589hg38
MDM (monocyte-derived macrophages), infect active H5N1 influenza, infection time 12hourGSM3112387, GSM3112388374094480271393455116486007hg38
MDM (monocyte-derived macrophages), infect UV-inactived H5N1 influenza, infection time 12hourGSM3112389, GSM3112390370873730271139299141891144hg38
MDM (monocyte-derived macrophages), infect mock, infection time 12hourGSM3112391, GSM3112392375325186269603223141590565hg38
MDM (monocyte-derived macrophages), infect active H5N1 influenza, infection time 18hourGSM3112393, GSM311239434254631524671053590107030hg38
MDM (monocyte-derived macrophages), infect UV-inactived H5N1 influenza, infection time 18hourGSM3112395, GSM3112396359582741263009661126662575hg38
MDM (monocyte-derived macrophages), infect mock, infection time 18hourGSM3112397, GSM311239824149492317602362982834015hg38
MDM (monocyte-derived macrophages), infect active H5N1 influenza, infection time 6hourGSM3112399, GSM3112400, GSM3111878, GSM31118791348816197775193565341289090hg38
MDM (monocyte-derived macrophages), infect UV-inactived H5N1 influenza, infection time 6hourGSM3112401, GSM3112402372341299273495677142104639hg38
MDM (monocyte-derived macrophages), infect mock, infection time 6hourGSM3112403, GSM3112404, GSM3111876, GSM31118771561401808891443631356578081hg38
MDM (monocyte-derived macrophages), infect H5N1-dNS1 influenza, infection time 6hourGSM3111880, GSM31118811081954822553987309231746456hg38
MDM (monocyte-derived macrophages), treat IFNb, 6hourGSM3111882, GSM3111883955245255487116744199473555hg38
H9 Human Embryonic Stem CellsGSM2309023312782126899156350181919119hg38
H9 human Embryonic Stem Cell Line, Heat shock conditionGSM2816609, GSM2816610601967908407959808166471296hg38
CD4+ T cellsGSM2627271, GSM262727220503831614744181130284233hg38
CD4+ T cells, activated using anti-CD3/CD28 beadGSM2627273, GSM262727418603888613400018028683992hg38
Na•ve CD4+ T cellsGSM282778622529975717025011081075757hg38
Na•ve CD4+ T cellsGSM282778725800099819568098794280663hg38
Na•ve CD8+ T cellsGSM282778824695169118425731781669241hg38
Na•ve CD8+ T cellsGSM282778922446968916906194881681918hg38
B cellsGSM2827790280648411212305488103487984hg38
B cellsGSM282779128052097921223098199240188hg38
MCF10a (epithelial cell line), arrested in G1GSM3110157, GSM3110158475958430347978572125736168hg38
MCF10a (epithelial cell line), arrested in G1 and transfected STAG1 siRNAGSM3110159, GSM3110160488301184358347580119713846hg38
MCF10a (epithelial cell line), arrested in G1 and transfected STAG2 siRNAGSM3110161, GSM3110162472317730346416380136441940hg38
HUVEC (Human umbilical vein endothelial cells), donor1GSM2595581382431967275209240110971928hg38
HUVEC (Human umbilical vein endothelial cells), donor2GSM259558233126085821074921566957102hg38
HUVEC (Human umbilical vein endothelial cells), donor3GSM2595583361226844257490619100597411hg38
IMR90 (fetal lung fibroblast cell), I10GSM259558432479112125543302772976466hg38
IMR90 (fetal lung fibroblast cell), I79GSM259558530934082823739413182507957hg38
MSC (mesenchymal stromal cells)GSM259558629077813221933621360801048hg38
HUVEC (Human umbilical vein endothelial cells), donor1, Oncogenic induced senescenceGSM2595587433798275308073201136048369hg38
HUVEC (Human umbilical vein endothelial cells), donor2, Oncogenic induced senescenceGSM2595588383019681267693856111074334hg38
HUVEC (Human umbilical vein endothelial cells), donor3, Oncogenic induced senescenceGSM259558935378784319066469537073623hg38
IMR90 (fetal lung fibroblast cell), I10, Oncogenic induced senescenceGSM259559036595587329596693863701043hg38
IMR90 (fetal lung fibroblast cell), I79, Oncogenic induced senescenceGSM259559133955607627079194169413884hg38
MSC (mesenchymal stromal cells), Oncogenic induced senescenceGSM259559234342113726620780383357956hg38
HUVEC (Human umbilical vein endothelial cells), donor2, Oncogenic induced senescence, treated with non-targeting control siRNAGSM259559339641761130055284616733122hg38
HUVEC (Human umbilical vein endothelial cells), treated with siRNA targeting HMGB2 (HMGB2-Knock Down)GSM259559439142669429518017811950450hg38
RUES2 (Embryonic stem cells), cardiac differentiation stage : Embryonic stem cells (ESC)GSM2845448, GSM284544932687990524746701483742737hg38
RUES2 (Embryonic stem cells), cardiac differentiation stage : mesoderm (MES)GSM2845450, GSM284545125014909318576861746113431hg38
RUES2 (Embryonic stem cells), cardiac differentiation stage : cardiac progenitor (CP)GSM2845452, GSM284545341773128531019063975138096hg38
RUES2 (Embryonic stem cells), cardiac differentiation stage : cardiomyocytes (CM)GSM2845454, GSM284545549392254935961360161699109hg38
RUES2 (Embryonic stem cells), fetal heartGSM2845456, GSM284545748933778732135262876808476hg38
WTC-11 (iPSCs), cardiac differentiation stage : pluripotent stem cells (PSC)GSM3452717, GSM345271833546755022920222380251558hg38
WTC-11 (iPSCs), cardiac differentiation stage : mesoderm (MES)GSM3452719, GSM345272024199219416143123352950578hg38
WTC-11 (iPSCs), cardiac differentiation stage : cardiac progenitor (CP)GSM3452721, GSM345272228230570117107400242892118hg38
WTC-11 (iPSCs), cardiac differentiation stage : cardiomyocytes (CM)GSM3452723, GSM345272435957616623778854059839164hg38
Human Hematopoietic Stem/Progenitor Cells (CD34+, CD38-)GSM28617081125460828725985897216969402hg38
Human T cell (CD3+)GSM286170996516764470253212494189553hg38
Human Erythroid Progenitor cells (CD36+, CD71+, CD235a+)GSM286171013777310511000420229282268773hg38
RWPE1 (prostate cell line)GSM2627219, GSM2627220940697596678377905285470097hg38
endothelial of hepatic sinusoid primary cellGSM2828874, GSM2828875730217738522713010271344681hg38
astrocyte of the spinal cord primary cellGSM2828825, GSM282882627642319310935469449930782hg38
endometrial microvascular endothelial primary cellGSM2827534, GSM282753537307942213303790960888465hg38
brain microvascular endothelial primary cellGSM2827278, GSM282727938797785414124442160870013hg38
brain pericyte primary cellGSM2827225, GSM28272262400159665911173412095981hg38
astrocyte of the cerebellum primary cellGSM2824366, GSM2824367715071720504740164247980517hg38
primary epidermal keratinocyte, Differentiation Day 0GSM2247305, GSM2247308473817144364191286205550840hg38
primary epidermal keratinocyte, Differentiation Day 3GSM2247306, GSM2247309449446525346772947189532396hg38
primary epidermal keratinocyte, Differentiation Day 6GSM2247307, GSM2247310435822471338426796151820165hg38
HAP1 (near-haploid cell line)GSM2494290, GSM2494294, GSM2494298622379602408952162173929026hg38
HAP1 (near-haploid cell line), WAPL knock OutGSM2494291, GSM2494295, GSM2494299593103406393669408182414787hg38
HAP1 (near-haploid cell line), SSC Knock OutGSM2494292, GSM2494296, GSM2494300653465572423459392155690711hg38
HAP1 (near-haploid cell line), WAPL and SSC Knock OUTGSM2494293, GSM2494297, GSM2494301644874296417017109163294093hg38
H9 Human Embryonic Stem CellsGSM230902331278212622787229376990193hg38
H9 Human ESC-derived Neuroectodermal CellsGSM230902428038475020450277569749331hg38
purified human na•ve B cellsGSM2225739, GSM2225740482533344282478362129481938hg38
purified human germinal center B cellsGSM2225741, GSM222574269959597248920992656161859hg38
Adrenal glandGSM232253921297787012787492231843460hg38
AortaGSM1419084777069820545141096123343548hg38
BladderGSM2322540 GSM232254153905846333505944466724835hg38
Dorsolateral Prefrontal CortexGSM232254218649846111294491937412569hg38
HippocampusGSM232254321204004412756042739547946hg38
LungGSM2322544 GSM232254535240396319420968833937230hg38
LiverGSM1419086949121479693065051161364911hg38
Left VentricleGSM14190851003815486707218005119249986hg38
OvaryGSM232254622675198213218651128091638hg38
PancreasGSM2322547 GSM2322548 GSM2322549 GSM232255036590712419281358441672175hg38
PsoasGSM2322551 GSM2322552 GSM232255333440720219634022632452891hg38
Right VentricleGSM232255474679829952448672499683550hg38
Small BowelGSM232255520564781711620546626555344hg38
SpleenGSM2322556 GSM232255743466739825966286543224514hg38
ThymusGSM141908379409831457563474963615707hg38
H1 Embroynic Stem CellGSM1267196 GSM126719719994190701342388287393804147hg38
H1 Mesendoderm CellGSM1267198 GSM126719914595445821049545038407820701hg38
H1 Mesenchymal Stem CellGSM1267200 GSM1267201973402930718127152407461596hg38
H1 Neuronal Progenitor CellGSM1267202 GSM126720315311631201050094717142246538hg38
H1 Trophectoderm CellGSM1267204 GSM12672051274418605862793423198533246hg38
fibroblast(CRL-2522) controlGSM21423991540727319032718419510925hg38
fibroblast(CRL-2522) dexamethasone 00hGSM214240016898644910764375324375407hg38
fibroblast(CRL-2522) dexamethasone 08hGSM21424011043989976881597516566433hg38
fibroblast(CRL-2522) dexamethasone 16hGSM2142402921505156020579514481892hg38
fibroblast(CRL-2522) dexamethasone 24hGSM2142403840000005510967614163578hg38
fibroblast(CRL-2522) dexamethasone 32hGSM2142404828432775462254713591175hg38
fibroblast(CRL-2522) dexamethasone 40hGSM21424051164428117931291517823572hg38
fibroblast(CRL-2522) dexamethasone 48hGSM21424061123613687605507417363407hg38
fibroblast(CRL-2522) dexamethasone 56hGSM21424071307461088945698221549275hg38
A549 00h 100 nM dexamethasoneGSM2437834 GSM2437835 GSM2437836 GSM2437837 GSM2437838
GSM2437839 GSM2437840 GSM2437841		24180019891561616864524984581hg38
A549 01h 100 nM dexamethasoneGSM2437749 GSM2437750 GSM2437751 GSM2437752 GSM2437753
GSM2437754 GSM2437755		23340228431526509389514912123hg38
A549 04h 100 nM dexamethasoneGSM2437783 GSM2437784 GSM2437785 GSM2437786 GSM2437787
GSM2437788 GSM2437789 GSM2437790		23160943761509752859535752790hg38
A549 08h 100 nM dexamethasoneGSM2437857 GSM2437858 GSM2437859 GSM2437860 GSM2437861
GSM2437862 GSM2437863 GSM2437864		21402074141396880280497153974hg38
A549 12h 100 nM dexamethasoneGSM2437806 GSM2437807 GSM2437808 GSM2437809 GSM2437810
GSM2437811 GSM2437812 GSM2437813		22700314571476433065539393081hg38
LNCap prostate cancer cell line, BglIIGSM1902607 GSM1902608 GSM1902609 GSM1902610
GSM1902611 GSM1902612 GSM1902613 GSM1902614		88962166967336021315118646hg38
PC3 prostate cancer cell line, BglIIGSM1902605 GSM190260617164047813177974017819725hg38
PrEC normal Prostate epithelial cell, BglIIGSM1902602 GSM1902603 GSM190260453541570338881123127408976hg38
HUVEC, in-situ MboIGSM1551629 GSM1551630 GSM1551631732108988483044556231820747hg38
IMR90, in-situ MboIGSM1551599 GSM1551600 GSM1551601 GSM1551602 GSM1551603 GSM1551604 GSM155160515352220821117646779543778098hg38
K562, in-situ MboIGSM1551618 GSM1551619 GSM1551620 GSM1551621 GSM1551622 GSM155162313662288451005752077472332302hg38
KBM7, in-situ MboIGSM1551624 GSM1551625 GSM1551626 GSM1551627 GSM15516281247936408928748600318829463hg38
NHEK, in-situ MboIGSM1551614 GSM1551615 GSM15516161073207572750552363251312047hg38
MCF-10AGSM163118428997507120551719213368580hg38
-MCF 7.00GSM16311852862862961953329399301812hg38
MCF-10A scramble shRNAGSM1930751 GSM19307522065038921435149366217083hg38
MCF-10A BRG1 shRNAGSM1930753 GSM19307542654343391880547009561853hg38
MCF-7 non-specific shRNAGSM1942100 GSM194210136265163627633685517083164hg38
MCF-7 RUNX1 shRNAGSM1942102 GSM194210337002185627877972914963495hg38
KBM7 cell lineGSM1709920 GSM170992156064308138227226359618162hg38
SK-N-DZ Cell LineGSM2825413, GSM282541429185382119901236121715217hg38
GM12878, in-situ MboIGSM1551552 GSM1551553 GSM1551554 GSM1551555
GSM1551556 GSM1551557 GSM1551558 GSM1551559 GSM1551560 GSM1551561
GSM1551562 GSM1551563 GSM1551564 GSM1551565 GSM1551566 GSM1551567
GSM1551569 GSM1551570 GSM1551571 GSM1551572 GSM1551573 GSM1551574
GSM1551575 GSM1551576 GSM1551577 GSM1551578 GSM1551597 GSM1551598
GSM1551682 GSM1551695 GSM1551696 GSM1551697 GSM1551699 GSM1551700
GSM1551701 GSM1551702 GSM1551703 GSM1551704 GSM1551705
GSM1551706 GSM1551707 GSM1551708 GSM1551709 GSM1551710 GSM1551711
GSM1551712 GSM1551713 GSM1551714 GSM1551715 GSM1551716 GSM1551717
GSM1551718 GSM1551719 GSM1551720 GSM1551721 GSM1551722 GSM1551723
GSM1551724 GSM1551725 GSM1551726 GSM1551727 GSM1551728 GSM1551730
GSM1551731 GSM1551732 GSM1551733 GSM1551734 GSM1551735
GSM1551736 GSM1551737 GSM1551738 GSM1551739
GSM1551740 GSM1551743 GSM1551746 GSM1551749		586494693344952909682079266425hg38
Sample & DescriptionGEO IdsTotal target readsTotal target reads without duplicatescis target reads (>15kb)Reference genome
Adrenal glandGSM2297098,GSM2297099,GSM2297100,GSM2297101,GSM2297102,GSM2297103534529915292052216438489hg19
AortaGSM2297104,GSM2297105,GSM2297106,GSM2297107,GSM2297108,
GSM2297109,GSM2297110,GSM2297111,GSM2297112,GSM2297113,
GSM2297114,GSM2297115,GSM2297116,GSM2297117,GSM2297118
,GSM2297119,GSM2297120,GSM2297121,GSM2297122		953734057796215424066751hg19
BladderGSM2297123,GSM2297124,GSM2297125,GSM2297126,GSM2297127,
GSM2297128,GSM2297129,GSM2297130,GSM2297131,GSM2297132,
GSM2297133,GSM2297134		565931695468667816122130hg19
CardiomyocytesGSM2297135,GSM2297136,GSM2297137,GSM2297138,GSM22971394220227266193829521695756hg19
EsophagusGSM2297146,GSM2297147,GSM2297148,GSM2297149,GSM2297150,GSM229715110374123103447632547084hg19
FATGSM2297152,GSM2297153,GSM2297154,GSM2297155,GSM2297156,GSM229715710616964105832733153844hg19
Gastric tissueGSM2297165,GSM2297166,GSM2297167,GSM2297168,GSM2297169,
GSM2297170,GSM2297171,GSM2297172,GSM2297173,GSM2297174,
GSM2297175,GSM2297176,GSM2297177		13895552311500347425563306hg19
GM12878+GM19240 Lymphoblastoid Cell LineGSM2297231,GSM2297232,GSM2297233,GSM2297234,GSM2297235,
GSM2297236,GSM2297237,GSM2297238,GSM2297239,GSM2297240,GSM2297241,
GSM2297242,GSM2297243,GSM2297244,GSM2297245,GSM2297246,GSM2297247,
GSM2297248,GSM2297249,GSM2297250,GSM2297251		14732314014380817860112159hg19
H1 Embroynic Stem CellGSM2297185,GSM2297186,GSM2297187,GSM2297188,GSM2297189,
GSM2297190,GSM2297191,GSM3067207,GSM3067208,GSM3067209,GSM3067210,
GSM3067211,GSM3067212,GSM3067213,GSM3067214,GSM3067215,GSM3067216		514240365060815718360249hg19
HippocampusGSM2297178,GSM2297179,GSM2297180,GSM2297181,GSM2297182,GSM2297183,GSM2297184882705556844971022857412hg19
Fibroblast cellsGSM2297158,GSM2297159,GSM2297160,GSM2297161,GSM2297162,GSM2297163,GSM2297164602521575039486720208593hg19
LungGSM2297208,GSM2297209,GSM2297210,GSM2297211,GSM2297212,
GSM2297213,GSM2297214,GSM2297215,GSM2297216,GSM2297217,
GSM2297218,GSM2297219,GSM2297220,GSM2297221,GSM2297222,GSM2297223,
GSM2297224,GSM2297225,GSM2297226,GSM2297227,GSM2297228,
GSM2297229,GSM2297230,GSM3067217		956815778742982419278659hg19
LiverGSM2297201,GSM2297202,GSM2297203,GSM2297204,GSM2297205,
GSM2297206,GSM2297207		502730604998191313917804hg19
Left VentricleGSM2297192,GSM2297193,GSM2297194,GSM2297195,
GSM2297196,GSM2297197,GSM2297198,GSM2297199,GSM2297200,
GSM3067218,GSM3067219		15259208710210555722803181hg19
H1-derived Mesendoderm CellGSM2297256424269854242698516852133hg19
H1-derived Mesenchymal Stem CellGSM2297252,GSM2297253,GSM2297254,GSM2297255320316723196579217922970hg19
H1-derived Neuronal Progenitor CellGSM229725752025048520250488439809hg19
OvaryGSM2297258,GSM2297259,GSM2297260,GSM2297261,GSM2297262,GSM2297263568750135656121611998440hg19
PancreasGSM2297264,GSM2297265,GSM2297266,GSM2297267,
GSM2297268,GSM2297269,GSM2297270,GSM2297271,GSM2297272,
GSM2297273,GSM2297274		1048015846897280218281393hg19
PsoasGSM2297275,GSM2297276,GSM2297277,GSM2297278,
GSM2297279,GSM2297280,GSM2297281,GSM2297282		32328663322515658743192hg19
Right heart atriumGSM2297283,GSM2297284,GSM2297285,
GSM2297286,GSM2297287,GSM2297288		910038190720442010420hg19
Right VentricleGSM2297289,GSM2297290,GSM2297291,GSM2297292,
GSM2297293,GSM2297294,GSM2297295,GSM2297296,GSM2297297		1085162727799518818862128hg19
Small BowelGSM2297304,GSM2297305,GSM2297306,GSM2297307,
GSM2297308,GSM2297309,GSM3067220		11670250910072631924677284hg19
Sigmoid colonGSM2297298,GSM2297299,GSM2297300,GSM2297301,
GSM2297302,GSM2297303		624334662221291739343hg19
SpleenGSM2297310,GSM2297311,GSM2297312,GSM2297313,
GSM2297314,GSM2297315,GSM2297316,GSM2297317,GSM3067221,
GSM3067222,GSM3067223,GSM3067224,GSM3067225		15761083911687883737228351hg19
TrophoblastGSM229732325427950254279509422392hg19
ThymusGSM2297318,GSM2297319,GSM2297320,GSM2297321,GSM2297322716642406991725014567128hg19
Dorsorateral prefrontal cortexGSM2297140,GSM2297141,GSM2297142,GSM2297143,
GSM2297144,GSM2297145,GSM3067226,GSM3067227,GSM3067228,
GSM3067229		24893697218642378984258470hg19
Sample & DescriptionGEO IdsRaw read countsProperly aligned readsValid interaction readsCancer typeSample typeReference genomeNote
T cell acute lymphoblastic leukemia (T-ALL)GSM396711819303279913094228596466328Acute_Myeloid_Leukemiacancer Hi-Chg38
T cell acute lymphoblastic leukemia (T-ALL)GSM396711919767920912096543368296578Acute_Myeloid_Leukemiacancer Hi-Chg38
T cell acute lymphoblastic leukemia (T-ALL)GSM396712026598754513903146881887865Acute_Myeloid_Leukemiacancer Hi-Chg38
T cell acute lymphoblastic leukemia (T-ALL)GSM396712120016188513146132675545449Acute_Myeloid_Leukemiacancer Hi-Chg38
Early T-lineage progenitor acute lymphoblastic leukemia (ETP-ALL)GSM3967122276855502189315287113394948Acute_Myeloid_Leukemiacancer Hi-Chg38
Early T-lineage progenitor acute lymphoblastic leukemia (ETP-ALL)GSM3967123316151698159556782107566067Acute_Myeloid_Leukemiacancer Hi-Chg38
Early T-lineage progenitor acute lymphoblastic leukemia (ETP-ALL)GSM3967124309176594194550254131150618Acute_Myeloid_Leukemiacancer Hi-Chg38
Early T-lineage progenitor acute lymphoblastic leukemia (ETP-ALL)GSM3967125266194234160701593109632441Acute_Myeloid_Leukemiacancer Hi-Chg38
Nalm6 (B cell precursor leukemia cell line)GSM32113911275566502994058249686270725Acute_Myeloid_Leukemiacancer Hi-Chg38
HL60/S4 (neutrophil-like Myeloid leukemia cell line)GSM3185669, GSM3185670, GSM318567113925630711168615919179898496Acute_Myeloid_Leukemiacancer Hi-Chg38
HL60/S4 (neutrophil-like Myeloid leukemia cell line), migrate through 5_m poresGSM3185672, GSM3185673, GSM318567414253048321213318509156486225Acute_Myeloid_Leukemiacancer Hi-Chg38
HL60/S4 (neutrophil-like Myeloid leukemia cell line), migrate through 14_m poresGSM3185675, GSM3185676, GSM318567714727542681269450782115879458Acute_Myeloid_Leukemiacancer Hi-Chg38
SK-N-SH (neuroblastoma cell line)GSM3192056360659622512401511184902Brain_Glioblastoma_Multiformecancer Hi-Chg38
SK-N-SH (neuroblastoma cell line), Heterozygous for the Pcdh_ gene cluster generated by CRISPR-Cas9GSM3192057415546032848405412677646Brain_Glioblastoma_Multiformecancer Hi-Chg38
U251 (glioblastoma cell line)GSM3567145, GSM3567146, GSM3567147, GSM356714824849447617764523619333130Brain_Glioblastoma_Multiformecancer Hi-Chg38
U251 (glioblastoma cell line), treat 1mM TMZ, 72hourGSM3567149, GSM356715023302542716622146922024184Brain_Glioblastoma_Multiformecancer Hi-Chg38
SK-N-MC (Ewing's sarcoma cell line)GSM2828694, GSM2828695313811254213786296168120056Brain_Glioblastoma_Multiformecancer Hi-Chg38
SK-MEL-5 (skin cancer cell line)GSM2827188, GSM282718930348269221662835476316058Brain_Glioblastoma_Multiformecancer Hi-Chg38
HCC1954 (Breast cancer cell line)GSM3258551307000648192881233123159628Breast_Cancercancer Hi-Chg38
MCF-7 (endocrine-sensitive breast cancer cells), grown without exposure to endocrine therapy, culture startGSM3756149,GSM37561501215163036144795125783799Breast_Cancercancer Hi-Chg38
MCF-7 (endocrine-sensitive breast cancer cells), grown without exposure to endocrine therapy, culture 3monthGSM3756151,GSM37561521041717645502934420784817Breast_Cancercancer Hi-Chg38
MCF-7 (endocrine-sensitive breast cancer cells), grown without exposure to endocrine therapy, culture 6monthGSM3756153,GSM37561541085393615634897720615675Breast_Cancercancer Hi-Chg38
MCF-7 (endocrine-sensitive breast cancer cells), endocrine-sensitive ER+ cellGSM3336890,GSM3336891,GSM3336892524174508368180101196366648Breast_Cancercancer Hi-Chg38
MCF-7 (endocrine-sensitive breast cancer cells), Tamoxifen-resistant (TAMR) cellGSM3336893,GSM3336894,GSM3336895547549934372437992198695296Breast_Cancercancer Hi-Chg38
MCF-7 (endocrine-sensitive breast cancer cells), Fulvestrant-resistant cellGSM3336896,GSM3336897,GSM3336898391118222275774008138825908Breast_Cancercancer Hi-Chg38
T-47D (ductal carcinoma cell line)GSM3044586, GSM3044588, GSM3044590775262422570818891207562883Breast_Cancercancer Hi-Chg38
T-47D (ductal carcinoma cell line), treat 110 mM NaCl, 1hourGSM3044586, GSM3044588, GSM3044592758804089561715369302976267Breast_Cancercancer Hi-Chg38
T-47D (ductal carcinoma cell line), treat 500 nM triptolide, 2hour prior stressGSM304459121709738316215851265221863Breast_Cancercancer Hi-Chg38
T-47D (ductal carcinoma cell line), treat 500 nM triptolide, 2hour prior stress and treat 110 mM NaCl, 1hourGSM304459323797929017791725868094499Breast_Cancercancer Hi-Chg38
T-47D (ductal carcinoma cell line), treat 110 mM NaCl, 1hour and isotonic meida recoveryGSM304459421620617116110839759305439Breast_Cancercancer Hi-Chg38
T-47D (ductal carcinoma cell line), treat 500 nM triptolide, 2hour prior stress -> treat 110 mM NaCl, 1hour -> isotonic meida recoveryGSM304459522639040216828063968038656Breast_Cancercancer Hi-Chg38
T47D (mammary ductal carcinoma cell line)GSM2827515, GSM2827516247702528739868478339227319Breast_Cancercancer Hi-Chg38
MCF10CA1a (fully malignant breast cancer cell)GSM2599095, GSM2599096415903729290561734146980469Breast_Cancercancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync control, STAG2 siRNA depletedGSM41067911334974287974345842570828085Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync controlGSM410678914740376251096634407508028022Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, ESCO siRNA depletedGSM4106797450331684335703425171035950Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, CTCF and STAG2 siRNA depletedGSM4106795478820518361666274155716678Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, CTCF and ESCO1 siRNA depletedGSM4106796621991903469213039312682032Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync control, auxin-inducible degron (AID) tag fused to STAG1, no auxin treatGSM410679822165456816076408792241896Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync controlGSM4106788439832590329547597128827283Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync control, auxin-inducible degron (AID) tag fused to STAG2, no auxin treatGSM410680024392871117549802496579758Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync control, STAG1 siRNA depletedGSM41067901369342451684678334401840636Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync control, auxin-inducible degron (AID) tag fused to STAG1, auxin treatGSM4106799233168235168228939104025583Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, CTCF and STAG1 siRNA depletedGSM4106802524372470388356198184814394Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, STAG1 siRNA depletedGSM4106792477857849353241842159787036Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, CTCF siRNA depletedGSM4106794529310863393671192185376865Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, MboI G1 sync control, auxin-inducible degron (AID) tag fused to STAG2, auxin treatGSM410680119276665613741973977798157Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto cell, HindIII G1 sync control, STAG2 siRNA depletedGSM4106793498530119374842559180759922Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa F2 cell, treated for 24 hours with 1000 U/ml of recombinant human IFNgGSM348942019005119711918873551817331Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, synchronized at G1GSM2747738439832590329547593128827288Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, WAPL depleted by RNA inferenceGSM2747739401825457298295379121433281Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Pds5SA/B depleted by RNA inferenceGSM2747740416096383311279545145477604Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, WAPL and Pds5SA/B depleted by RNA inferenceGSM2747741478685424352573375179019299Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, synchronized at ProMeta-phaseGSM2747742567505689381400441201561605Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, synchronized at SGSM2747743563598410404009504185650152Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, synchronized at G2GSM2747744469250696338041622172751017Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, 0minGSM2747745, GSM2747748470901785362811632166125583Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, 15minGSM274774621373622216362516373833724Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, 180minGSM274774720233315515232287472530006Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, 120minGSM274774927773108821320273598841687Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa KyotoGSM274775025001149218248966185533030Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, CTCF-auxin inducible degradation, 0minGSM274775119332094014864438968672788Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, CTCF-auxin inducible degradation, 120minGSM274775225639776519567313174981875Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, WAPL and Pds5SA/B depleted by RNA inference, 0minGSM2747753286703129219745687106011769Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, WAPL and Pds5SA/B depleted by RNA inference, 15minGSM274775426386737620177998298221504Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
HeLa Kyoto, Scc1-auxin inducible degradation, WAPL and Pds5SA/B depleted by RNA inference, 180minGSM274775527574484020933784685529247Cervical_Squamous_Cell_Carcinomacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CTCF-auxin inducible degradation, treat AUX, 24hourGSM4198767, GSM4198771465865280353386514255131882Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CTCF-auxin inducible degradation, treat DMSO, 168hourGSM4198768, GSM4198772479596495361947852265290366Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 9hourGSM4198746, GSM4198756583026816432495135302453530Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domainGSM4198745, GSM4198755622131622459031035330061827Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 18hourGSM4198747, GSM4198757532594603392497055282295427Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 24hourGSM4198748, GSM4198758566734963414177399284885599Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 72hourGSM4198750, GSM4198760556616461402980539277968872Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 120hourGSM4198752, GSM4198762519515589377089534261362720Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CTCF-auxin inducible degradation, treat DMSO, 24hourGSM4198766, GSM4198770512188670388419973279641145Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 96hourGSM4198751, GSM4198761589211629434980151314192501Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 144hourGSM4198753, GSM4198763576709794425268020310290677Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 168hourGSM4198754, GSM4198764546596448396780826277109452Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CTCF-auxin inducible degradation, treat AUX, 168hourGSM4198769, GSM4198773495575272372849896271838196Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CTCF-auxin inducible degradationGSM4198765248644064183405393121304011Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
BLaER (lymphoblastic leukemia cell line), CEBPA fused with the estrogen receptor (ER) hormone-binding domain, induced 48hourGSM4198749, GSM4198759583502120433365827312042799Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
K562 (chronic myelogenous leukemia cell line), heat shock, after 30minGSM3753207, GSM375320821338881410759497784758898Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
K562 (chronic myelogenous leukemia cell line), heat shock, before 30min (control)GSM3753209, GSM375321021491798010783912185566155Chronic_Lymphocytic_Leukemiacancer Hi-Chg38
HCT116_CRISPR_D134in-house41055817931045987621375371Colon_Adenocarcinomacancer Hi-Chg38
SW480 (Colon cancer cell line), treated with siRNA targeting TCF7L2, 48hour elapsedGSM459444818130813711630275236211178Colon_Adenocarcinomacancer Hi-Chg38
SW480 (Colon cancer cell line), treated with siRNA targeting TCF7L2, 24hour elapsedGSM45944471349263708569539128289587Colon_Adenocarcinomacancer Hi-Chg38
HCT116_CRISPR_GFPin-house16828902612197089446312852Colon_Adenocarcinomacancer Hi-Chg38
SW480 (Colon cancer cell line), treated with siRNA targeting TCF7L2, 72hour elapsedGSM459444917913985311322948032944595Colon_Adenocarcinomacancer Hi-Chg38
SW480 (Colon cancer cell line), negative controlGSM45944461121154907185506722497632Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-328T (Korean colorectal cancer patient tissue, stage III)in-house1016866474362066760321609402Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_12-251T (Korean colorectal cancer patient tissue, stage III)in-house1210877828445048545388355992Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_15-446T (Korean colorectal cancer patient tissue, stage III)in-house916730868334685711304597659Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-1083T (Korean colorectal cancer patient tissue, stage III)in-house1145063964419052208376392291Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1413T (Korean colorectal cancer patient tissue, stage III)in-house628874197463368857400123137Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-542T (Korean colorectal cancer patient tissue, stage III)in-house726621467541981767480629779Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-151T (Korean colorectal cancer patient tissue, stage III)in-house818660971628465310521665179Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1317T (Korean colorectal cancer patient tissue, stage III)in-house298009919212634363204822353Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_15-418T (Korean colorectal cancer patient tissue, stage III)in-house785066885456611319408145804Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-810T (Korean colorectal cancer patient tissue, stage III)in-house805136438301791043280946525Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-326T (Korean colorectal cancer patient tissue, stage III)in-house482282490355409488327393059Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-1074T (Korean colorectal cancer patient tissue, stage III)in-house984601002366762119317184620Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-63T (Korean colorectal cancer patient tissue, stage III)in-house550068401402577420361863901Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_15-1382T (Korean colorectal cancer patient tissue, stage III)in-house812722208295250914271145517Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-52T (Korean colorectal cancer patient tissue, stage III)in-house1216914618453236607398507239Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-426T (Korean colorectal cancer patient tissue, stage III)in-house482191004360317858331738554Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-442T (Korean colorectal cancer patient tissue, stage III)in-house519658705385872114350674378Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1410T (Korean colorectal cancer patient tissue, stage III)in-house578470936436927972378770443Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-545T (Korean colorectal cancer patient tissue, stage III)in-house564765772417869263368839819Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1321T (Korean colorectal cancer patient tissue, stage III)in-house563181589415329729348250452Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-927T (Korean colorectal cancer patient tissue, stage III)in-house534368946393544986357884287Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_09-376T (Korean colorectal cancer patient tissue, stage III)in-house898666006333040669297637843Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_15-1420T (Korean colorectal cancer patient tissue, stage IV)in-house537908101393673874355607090Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1334T (Korean colorectal cancer patient tissue, stage III)in-house1085370254414620702361238626Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1320T (Korean colorectal cancer patient tissue, stage III)in-house426016679316923049274445347Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-257T (Korean colorectal cancer patient tissue, stage III)in-house498018585368228643333516820Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-275T (Korean colorectal cancer patient tissue, stage III)in-house1011160752372086657335829814Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-494T (Korean colorectal cancer patient tissue, stage III)in-house425579257317246279294434533Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-1483T (Korean colorectal cancer patient tissue, stage IV)in-house416315674314015561266828152Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-114T (Korean colorectal cancer patient tissue, stage III)in-house370480745280948840252825471Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-258T (Korean colorectal cancer patient tissue, stage III)in-house430690459319915005258378529Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-91T (Korean colorectal cancer patient tissue, stage III)in-house393399210302811121255630334Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-51T (Korean colorectal cancer patient tissue, stage III)in-house224138840158257932152291160Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-1251T (Korean colorectal cancer patient tissue, stage III)in-house870219271654380248543113422Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_16-178T (Korean colorectal cancer patient tissue, stage III)in-house906664712335959814304190187Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-983T (Korean colorectal cancer patient tissue, stage III)in-house1086107826399716864360345103Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_13-731T (Korean colorectal cancer patient tissue, stage III)in-house456591112335460287300322158Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_11-1026T (Korean colorectal cancer patient tissue, stage III)in-house441190438324944476299980665Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-132T (Korean colorectal cancer patient tissue, stage III)in-house956439482354875863320172870Colon_Adenocarcinomacancer Hi-Chg38
SNUCRC_14-431T (Korean colorectal cancer patient tissue, stage III)in-house563315086408070272367236854Colon_Adenocarcinomacancer Hi-Chg38
SW480_ (Colon cancer cell line)GSM339974518702647611474102186040663Colon_Adenocarcinomacancer Hi-Chg38
SW480_rep1 (Colon cancer cell line)GSM339974619031540011716733088403786Colon_Adenocarcinomacancer Hi-Chg38
SW480_rep2 (Colon cancer cell line)GSM3258549377341876231908351174441896Colon_Adenocarcinomacancer Hi-Chg38
SNU-C1 (Colon cancer cell line)GSM3258550339918762205302613152349841Colon_Adenocarcinomacancer Hi-Chg38
HCT116 cell, auxin-inducible degron (AID) tag fused to STAG1, no auxin treatGSM3898434, GSM389843674391155161246922192224538Colon_Adenocarcinomacancer Hi-Chg38
HCT116 cell, auxin-inducible degron (AID) tag fused to STAG1, auxin treatGSM3898435, GSM389843772625392559329792384862533Colon_Adenocarcinomacancer Hi-Chg38
HCT116 cell, auxin-inducible degron (AID) tag fused to STAG2, no auxin treatGSM3898438, GSM3898440769369877635106247106374736Colon_Adenocarcinomacancer Hi-Chg38
HCT116 cell, auxin-inducible degron (AID) tag fused to STAG2, auxin treatGSM3898439, GSM3898441763091360631503667102417490Colon_Adenocarcinomacancer Hi-Chg38
DLD-1 (colorectal cancer cell line)GSM2825476, GSM2825477404191479266737379171908739Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, G1 synchronizedGSM2809546, GSM2809547, GSM2809548, GSM280954922028946915903339393780861Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, G1 synchronized, 6hour axin treatGSM2809550, GSM2809551, GSM2809552, GSM280955324199282617252773092724959Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 20min withdrawalGSM2809563, GSM2809564, GSM2809565, GSM2809566950805510638636233310340932Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 40min withdrawalGSM2809567, GSM2809568, GSM2809569, GSM2809570952354170639322841297464144Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 60min withdrawalGSM2809571, GSM2809572, GSM2809573, GSM2809574908648083606838999269739393Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 180min withdrawalGSM2809575, GSM2809576, GSM2809577, GSM2809578934030332638317762313873322Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, controlGSM2809579, GSM2809580, GSM2809591, GSM2809592230850311753910311423204Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 20min axin treatGSM2809581, GSM280958214714658109884658131952Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 40min axin treatGSM2809583, GSM28095841174188488227106881622Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 60min axin treatGSM2809585, GSM28095861284350595617026389052Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 4hour axin treatGSM2809587, GSM2809588260870681958611613958259Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treatGSM2809589, GSM2809590, GSM2809593, GSM2809594256973701937030812981860Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 20min withdrawalGSM2809601, GSM28096021119021184433815705605Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 40min withdrawalGSM2809603, GSM2809604992423674581934918019Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 60min withdrawalGSM2809605, GSM2809606754384356736563669498Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 3hour withdrawalGSM2809607, GSM2809608396699443017416520492648Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 6hour withdrawalGSM2809595, GSM2809596347452902631934317962616Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 18hour withdrawalGSM2809597, GSM2809598380424012906846719702061Colon_Adenocarcinomacancer Hi-Chg38
HCT-116 (colorectal cancer cell line), RAD21 alleles were tagged with an AID domain and a fluorescent mClover, 6hour axin treat, 24hour withdrawalGSM2809599, GSM2809600437110823346021123870347Colon_Adenocarcinomacancer Hi-Chg38
OE33 (Esophegeal adenocarcinoma cell line)GSM3258552417226018297042519145894672Esophageal_Adenocarcinomacancer Hi-Chg38
SNU16 (gastric cancer cell line)GSM3327706648672493413369981188778330Gastric_Cancercancer Hi-Chg38
T2000877 (gastric cancer cell line), CCNE1-rearranged gastric cancer cell lineGSM3333325677031899453076155136087596Gastric_Cancercancer Hi-Chg38
T990275 (gastric cancer cell line), CCNE1-rearranged gastric cancer cell lineGSM3356360697358488473569205141399494Gastric_Cancercancer Hi-Chg38
293TRex-Flag-BRD4-NUT-HA, treat 1 _g/mL tetracycline for 8 hoursGSM3901271, GSM390127220381858121375543153805027128Kidney_Renal_Clear_Cell_Carcinomacancer Hi-Chg38
786-O cell line (renal cancer cell line)GSM2631392, GSM263139440640766725599401595951889Kidney_Renal_Clear_Cell_Carcinomacancer Hi-Chg38
786-M1A cell line (renal cancer cell line)GSM2631393, GSM263139531276159119791574984268637Kidney_Renal_Clear_Cell_Carcinomacancer Hi-Chg38
G-401 (kidney cancer cell line)GSM2825105, GSM2825106340927844239661440108648697Kidney_Renal_Clear_Cell_Carcinomacancer Hi-Chg38
HepG2 (hepatocellular carcinoma cell line)GSM2825569, GSM2825570340311943020409332221281995118Liver_Hepatocellular_carcinomacancer Hi-Chg38
NCI-H460 (lung cancer cell line)GSM2827554, GSM2827555313205689218089310142941579Lung_Squamous_Cell_Carcinomacancer Hi-Chg38
A549 (lung cancer cell line)GSM2827368, GSM2827369251891733168970500130644353Lung_Squamous_Cell_Carcinomacancer Hi-Chg38
Jurkat (T lymphocyte cell line), controlGSM40052909847232036465798508175941Malignant_Lymphomacancer Hi-Chg38
Jurkat (T lymphocyte cell line), Inversion of -31kb CTCF binding siteGSM40052918326805485698460118807374Malignant_Lymphomacancer Hi-Chg38
T lymphocytes, DMSO treatGSM2978427, GSM297842854913528740647024389371512Malignant_Lymphomacancer Hi-Chg38
T lymphocytes, UNC4976 treat (PRC1 inhibitor)GSM2978429, GSM2978430633167638453172588136592418Malignant_Lymphomacancer Hi-Chg38
CUTLL1 (T-ALL cell lines), 1_M DMSO treat every 12h for 72h, HindIIIGSM3967126, GSM3967127605798532458322653328317192Malignant_Lymphomacancer Hi-Chg38
CUTLL1 (T-ALL cell lines), 1_M DMSO treat every 12h for 72h treat, ArimaGSM3967131, GSM3967132440148654290573710173621361Malignant_Lymphomacancer Hi-Chg38
Jurkat (T-ALL cell lines), 1_M DMSO treat every 12h for 72hGSM3967128293286388218907550161074818Malignant_Lymphomacancer Hi-Chg38
CUTLL1 (T-ALL cell lines), 1_M _SI treat every 12 h for 72hGSM3967129, GSM3967130567807660429902058317043468Malignant_Lymphomacancer Hi-Chg38
CUTLL1 (T-ALL cell lines), 100nM THZ1 treat every 12h for 24hGSM3967133, GSM3967134488711488320350523196790125Malignant_Lymphomacancer Hi-Chg38
RMG1 (Ovarian clear cell adenocarcinoma cell line)GSM33927001129233908650912961520686Ovarian_Cancercancer Hi-Chg38
RMG1 (Ovarian clear cell adenocarcinoma cell line), ARID1A Knock OutGSM3392701, GSM339270241571799131350339982617964Ovarian_Cancercancer Hi-Chg38
RMG1 (Ovarian clear cell adenocarcinoma cell line), NCAPH2 knock DownGSM3392703, GSM3392704324744057250619416178653125Ovarian_Cancercancer Hi-Chg38
Panc1 (pancreatic carcinoma cell line)GSM2827313, GSM282731428897805220702281195287825Pancreatic_Cancercancer Hi-Chg38
22Rv1 (prostate cancer cell line)GSM3358191, GSM33581921160817606827336464435540431Prostate_Adenocarcinomacancer Hi-Chg38
LNCaP (prostate adenocarcinoma cell line)GSM2827298, GSM2827299306489193201367841140340910Prostate_Adenocarcinomacancer Hi-Chg38
ACHN (renal cell adenocarcinoma cell line)GSM2827296, GSM2827297318594372186275752124002469Renal_Cell_Cancercancer Hi-Chg38
Caki2 (Renal cancer cell line)GSM2827127, GSM2827128323731060230583858117665509Renal_Cell_Cancercancer Hi-Chg38
HT1080 (fibrosarcoma cell line)GSM3304262, GSM330426445963928929056501791128189Sarcomacancer Hi-Chg38
HT1080 (fibrosarcoma cell line), treat 3_m CBL0137(curaxin), 6hourGSM3304263, GSM330426547726410929392810788614820Sarcomacancer Hi-Chg38
SJCRH30 (rhabdomyosarcoma cell line)GSM2828914, GSM28289151522357501452114110061781Sarcomacancer Hi-Chg38
RPMI-7951 (Skin Malignant Melanoma Cell line)GSM2828922, GSM2828923335883359238065916177726868Skin_Cutaneous_melanomacancer Hi-Chg38
SNUCRC_14-151N (Korean colorectal cancer patient tissue, paired-normal)in-house884920598659322576536474206Paired-normalcancer matched normal Hi-Chg38
SNUCRC_13-542N (Korean colorectal cancer patient tissue, paired-normal)in-house664606156487362479445020078Paired-normalcancer matched normal Hi-Chg38
SNUCRC_11-52N (Korean colorectal cancer patient tissue, paired-normal)in-house427338618317768703280699608Paired-normalcancer matched normal Hi-Chg38
SNUCRC_12-251N (Korean colorectal cancer patient tissue, paired-normal)in-house421661262315148822283218551Paired-normalcancer matched normal Hi-Chg38
SNUCRC_11-1074N (Korean colorectal cancer patient tissue, paired-normal)in-house422467745316431115279706985Paired-normalcancer matched normal Hi-Chg38
SNUCRC_11-63N (Korean colorectal cancer patient tissue, paired-normal)in-house421129540310249164281705261Paired-normalcancer matched normal Hi-Chg38
SNUCRC_11-51N (Korean colorectal cancer patient tissue, paired-normal)in-house386903406278712486265520456Paired-normalcancer matched normal Hi-Chg38
SNUCRC_13-731N (Korean colorectal cancer patient tissue, paired-normal)in-house410379473301824636259747589Paired-normalcancer matched normal Hi-Chg38
SNUCRC_16-178N (Korean colorectal cancer patient tissue, paired-normal)in-house432730343317145590281835009Paired-normalcancer matched normal Hi-Chg38
SNUCRC_14-1251N (Korean colorectal cancer patient tissue, paired-normal)in-house886088033669433528551923980Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), uninducedGSM3735774, GSM3735775881779242648328824216343943Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), Oncogene induces senescence day2GSM3735776, GSM3735777883676690646036417332793503Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), Oncogene induces senescence day4GSM3735778, GSM3735779882422192644836721398445428Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), Oncogene induces senescence day6GSM3735780, GSM3735781882614218630127410437030479Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), Oncogene induces senescence day10GSM3735782, GSM3735783883468687655227988403561929Paired-normalcancer matched normal Hi-Chg38
WI38 Primary Fibrolabsts, replicative senescence - proliferativeGSM3735784, GSM3735785883066011638022950344703900Paired-normalcancer matched normal Hi-Chg38
WI38 Primary Fibrolabsts, replicative senescence - senescenceGSM3735786, GSM3735787884354567657051143431130856Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), Oncogene induces senescence day5, treat siDNMT1GSM3735788, GSM3735789498071418351580282313389599Paired-normalcancer matched normal Hi-Chg38
WI38_RAF (WI-38hTERT/GFP-RAF1-ER), Oncogene induces senescence day5, treat siNT1GSM3735790265301308211197944173178837Paired-normalcancer matched normal Hi-Chg38
Primary CD4+ T-cellsGSM4119020, GSM4119025441336765326967611229420799Paired-normalcancer matched normal Hi-Chg38
Primary CD4+ T-cells, CD3/CD28 stimulated, 20minGSM4119021, GSM4119026457097949341339878248371235Paired-normalcancer matched normal Hi-Chg38
Primary CD4+ T-cells, CD3/CD28 stimulated, 1hrGSM4119022, GSM4119027471820743352237269253395091Paired-normalcancer matched normal Hi-Chg38
Primary CD4+ T-cells, CD3/CD28 stimulated, 4hrGSM4119023, GSM4119028396495233297996877223291925Paired-normalcancer matched normal Hi-Chg38
Primary CD4+ T-cells, CD3/CD28 stimulated, 24hrGSM4119024227352705170230000128639498Paired-normalcancer matched normal Hi-Chg38
IMR90 (Lung fibroblast-derived myoblast), control vectorGSM2597682, GSM25976831238966667858991824565423161Paired-normalcancer matched normal Hi-Chg38
IMR90 (Lung fibroblast-derived myoblast), TET-inducible MYOD, Growth mediaGSM2597684, GSM259768514418532521000879427673810174Paired-normalcancer matched normal Hi-Chg38
IMR90 (Lung fibroblast-derived myoblast), TET-inducible MYOD, differentiation mediaGSM2597686, GSM259768718039322131238805865866128695Paired-normalcancer matched normal Hi-Chg38
Peripheral blood T cellsGSM3967114241953113182004914143471144Paired-normalcancer matched normal Hi-Chg38
Peripheral blood T cellsGSM39671151017588937534114959417144Paired-normalcancer matched normal Hi-Chg38
Peripheral blood T cellsGSM396711622778062215644489898861174Paired-normalcancer matched normal Hi-Chg38
MCF10AT1 (hyperplastic breast cell)GSM2599093, GSM2599094428654193298439062138228509Paired-normalcancer matched normal Hi-Chg38